Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease-Reference-Cited by-同舟云学术

Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease

Published:2018-02-07 Issue:7 Volume:91 Page:1308-1317
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Yeo Khung-Keong¹²^ORCID,Armstrong Ehrin J.¹³^ORCID,López Javier E.⁴,Chen Debbie C.⁵,Westin Gregory G.⁶,Li Chin-Shang⁷,Anderson David⁸,Hua Amy⁴,Singapuri Anil⁴,Amsterdam Ezra A.⁴,Chiamvimonvat Nipavan⁴⁹,Laird John R.¹

Affiliation:

1. Division of Cardiovascular Medicine and the Vascular Center; University of California; Davis California

2. Department of Cardiology; National Heart Centre Singapore; Singapore, Singapore

3. Division of Cardiology; VA Eastern Colorado Healthcare System; Denver Colorado

4. Division of Cardiovascular Medicine; University of California; Davis California

5. Department of Medicine; Massachusetts General Hospital; Boston Massachusetts

6. Division of Vascular and Endovascular Surgery; NYU Langone Medical Center; New York New York

7. Division of Biostatistics, Department of Public Health Sciences; University of California; Davis California

8. Department of Internal Medicine; University of California; San Francisco California

9. Department of Veterans Affairs; Northern California Health Care System; Mather California

Funder

National Institutes of Health

VA Merit Review

Robert Wood Johnson Foundation

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences (NCATS)

National Institutes of Health (NIH)

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference43 articles.

1. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Rooke;J Am Coll Cardiol,2011

2. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Anderson;Circulation,2013

3. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines;Gerhard-Herman;J Am Coll Cardiol,2017

4. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients;Grotemeyer;Thromb Res,1993

5. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease;Gum;J Am Coll Cardiol,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study;Thrombosis Research;2024-04

2. Impact of Platelet Hyperreactivity and Diabetes Mellitus on Ischemic Stroke Recurrence: A Single-Center Cohort Clinical Study;International Journal of General Medicine;2024-03

3. Impact of Platelet Reactivity on 1-Year Clinical Outcomes After Endovascular Therapy for Femoropopliteal Lesions;The American Journal of Cardiology;2024-03

4. A review of clopidogrel resistance in lower extremity arterial disease;JVS-Vascular Insights;2024

5. High on-treatment platelet reactivity in peripheral arterial disease: A systematic review;Vascular;2023-11-11